Xiaosai Yao

14PUBLICATIONS
161CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Mineral processing/beneficiationGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 29, 2026
E3 Ubiquitin Ligase Mind Bomb 1 is a Novel Negative Regulator of Tumor-Suppressive BMP Signaling.

|Apr 01, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Jing Han Hong, Chern Han Yong, Hong Lee Heng

|Mar 05, 2026
The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1-Resistant Cancer.

Juliette Roels, Hamid Ghaedi, Jayaram Kancherla

|Feb 04, 2026
ZNF395 Is a Hypoxia-Responsive Regulator of Mitochondrial Glutaminolysis in Clear Cell Renal Cell Carcinoma.

Joanna Koh, Chengheng Liao, Michelle Shu Wen Ng

|Jan 14, 2026
A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.

Phillip Thienger, Irene Paassen, Xiaosai Yao

|Aug 02, 2025
Epiregulon: Single-cell transcription factor activity inference to predict drug response and drivers of cell states.

Tomasz Włodarczyk, Aaron Lun, Diana Wu

Pageof 3

Frequent Collaborators

4 joint publications

Patrick Tan

4 joint publications

Bin Tean Teh

3 joint publications

Marc Hafner

3 joint publications

Anwesha Dey